Search

Benjamin John Spink

from San Carlos, CA
Age ~48
Get Report
Also known as:
Benjamin J Spink, Ben J Spink, Beniamin Spink
Phone and address:
379 Northam Ave, San Carlos, CA 94070
(650) 591-2988
Related to:
Jack Spink, 53Sarah M Spink, 46Katharine E Spink, 49Mary Spink, 76Sharon K Eklof, 79Michael Spink, 75Andrew C Benish, 48Alice R Eklof, 46Paul C Eklof, 81
Connected to:
Adam M Spink, 42Alison C Spink, 64Amy Spink, 34Ben R Spink, 35Cheryl R Spink, 60David T Spink, 63Dee Spink, 53Emily A Spink, 29Holly J Spink, 53Jeffrey A Spink, 51

Benjamin Spink Phones & Addresses

  • 379 Northam Ave, San Carlos, CA 94070 (650) 591-2988
  • 1521 Cedar St, San Carlos, CA 94070 (650) 591-2988
  • Palo Alto, CA
  • Menlo Park, CA
  • Sunnyvale, CA
  • San Mateo, CA
  • Carmel, IN
  • 379 Northam Ave, San Carlos, CA 94070

Work

Position: Clerical/White Collar

Education

Degree: Associate degree or higher

Industries

Biotechnology

Resumes

Resumes

Benjamin Spink Photo 1

Scientist At Amunix

View page
Location:
San Francisco Bay Area
Industry:
Biotechnology

Publications

Us Patents

Comprehensive Verification Systems And Methods For Analyzer-Read Clinical Assays

View page
US Patent:
6629057, Sep 30, 2003
Filed:
Nov 5, 1999
Appl. No.:
09/435253
Inventors:
Stephen E. Zweig - Los Gatos CA
Thomas D. Downey - Cupertino CA
Benjamin J. Spink - Stanford CA
Benjamin G. Meyer - Saratoga CA
Assignee:
Beckman Coulter, Inc. - Fullerton CA
International Classification:
G06F 1130
US Classification:
702182, 73 73, 374102
Abstract:
The present invention provides improved systems and methods for verifying accurate test performance of monitoring systems, particularly for point-of-care service. Such monitoring systems typically include a test element containing the test reagent(s), and an electronic analyzer device. A blood or other patient sample is applied to the test element, which is introduced to the analyzer. As the reaction proceeds, the analyzer stores the data and outputs the testing result. Accuracy in the result is dependent upon proper functioning of both the test element and the analyzer. The systems of the present invention provide indicators to evaluate the integrity of the test elements and a verification device to evaluate the performance of the analyzer. Such systems may be provided as kits with instructions for use.

Extended Recombinant Polypeptides And Compositions Comprising Same

View page
US Patent:
20100239554, Sep 23, 2010
Filed:
Feb 3, 2010
Appl. No.:
12/699761
Inventors:
Volker Schellenberger - Palo Alto CA, US
Joshua Silverman - Sunnyvale CA, US
Benjamin Spink - San Carlos CA, US
Willem P. Stemmer - Los Gatos CA, US
Nathan C. Geething - Santa Clara CA, US
Wayne To - Fremont CA, US
Jeffrey L. Cleland - San Carlos CA, US
International Classification:
A61K 38/48
C07K 14/46
C12N 9/64
C07K 14/61
C07H 21/04
C12N 15/63
C12N 1/21
C12N 5/10
A61P 3/10
A61P 3/04
A61P 3/08
A61P 3/06
A61P 7/04
A61P 9/12
A61P 9/10
A61P 5/06
A61P 1/04
A61P 19/02
A61K 38/27
A61K 38/16
A61K 38/26
A61K 38/23
A61K 38/31
A61P 5/22
A61K 38/22
A61K 38/18
A61K 38/36
US Classification:
424 943, 530350, 435226, 530399, 536 234, 536 231, 4353201, 43525233, 435358, 514 48, 514 51, 514 69, 514 72, 514 73, 514 119, 514 111, 514 126, 514 91, 514 123, 514 117, 514 67, 514 137, 514 157, 514 212
Abstract:
The present invention relates to compositions comprising biologically active proteins linked to extended recombinant polypeptide (XTEN), isolated nucleic acids encoding the compositions and vectors and host cells containing the same, and methods of using such compositions in treatment of glucose-related diseases, metabolic diseases, coagulation disorders, and growth hormone-related disorders and conditions.

Coagulation Factor Ix Compositions And Methods Of Making And Using Same

View page
US Patent:
20110046060, Feb 24, 2011
Filed:
Aug 2, 2010
Appl. No.:
12/806004
Inventors:
Volker Schellenberger - Palo Alto CA, US
Joshua Silverman - Sunnyvale CA, US
Willem Stemmer - Los Gatos CA, US
Chia-wei Wang - Milpitas CA, US
Benjamin Spink - San Carlos CA, US
Nathan Geething - Santa Clara CA, US
Wayne To - Fremont CA, US
Assignee:
Amunix Operating, Inc., - Mountain View CA
International Classification:
A61K 38/36
C07K 14/745
A61P 7/04
US Classification:
514 137, 530381
Abstract:
The present invention relates to compositions comprising factor IX coagulation factors linked to extended recombinant polypeptide (XTEN), isolated nucleic acids encoding the compositions and vectors and host cells containing the same, and methods of making and using such compositions in treatment of coagulation factor-related diseases, disorders, and conditions.

Coagulation Factor Vii Compositions And Methods Of Making And Using Same

View page
US Patent:
20110046061, Feb 24, 2011
Filed:
Aug 2, 2010
Appl. No.:
12/806005
Inventors:
Volker Schellenberger - Palo Alto CA, US
Joshua Silverman - Sunnyvale CA, US
Willem Stemmer - Los Gatos CA, US
Chia-wei Wang - Milpitas CA, US
Benjamin Spink - San Carlos CA, US
Nathan Geething - Santa Clara CA, US
Wayne To - Fremont CA, US
Assignee:
Amunix Operating, Inc. - Mountain View CA
International Classification:
A61K 38/36
C07K 16/00
A61P 7/02
US Classification:
514 137, 530381
Abstract:
The present invention relates to compositions comprising factor VII coagulation factors linked to extended recombinant polypeptide (XTEN), isolated nucleic acids encoding the compositions and vectors and host cells containing the same, and methods of making and using such compositions in treatment of coagulation factor-related diseases, disorders, and conditions.

Factor Viii Compositions And Methods Of Making And Using Same

View page
US Patent:
20120178691, Jul 12, 2012
Filed:
Mar 16, 2012
Appl. No.:
13/423031
Inventors:
Volker Schellenberger - Palo Alto CA, US
Pei-Yun Chang - Menlo Park CA, US
Fatbardha Varfaj - Mountain View CA, US
Joshua Silverman - Sunnyvale CA, US
Chia-Wei Wang - Milpitas CA, US
Benjamin Spink - San Carlos CA, US
Nathan Geething - San Juan PR, US
Assignee:
Amunix Operating Inc. - Mountain View CA
International Classification:
A61K 38/37
C12N 15/62
C12N 15/63
A61P 7/04
C12N 1/19
C12N 1/15
C12N 1/21
C07K 19/00
C12N 5/10
US Classification:
514 141, 530383, 536 234, 4353201, 435325, 435365, 435352, 435358, 435369, 435353, 435354, 435366, 4352542, 43525421, 43525423, 43525411, 4352543, 4352544, 4352547, 4352546, 4352523, 43525233, 43525231, 43525234, 43525235
Abstract:
The present invention relates to compositions comprising factor VIII coagulation factors linked to extended recombinant polypeptide (XTEN), isolated nucleic acids encoding the compositions and vectors and host cells containing the same, and methods of making and using such compositions in treatment of factor VIII-related diseases, disorders, and conditions.

Coagulation Factor Vii Compositions And Methods Of Making And Using Same

View page
US Patent:
20120263701, Oct 18, 2012
Filed:
Aug 2, 2010
Appl. No.:
13/392509
Inventors:
Volker Schellenberger - Los Gatos CA, US
Willem P. Stemmer - Los Gatos CA, US
Nathan C. Geething - San Juan PR, US
Wayne To - Fremont CA, US
Joshua Silverman - Sunnyvale CA, US
Chia-wei Wang - Milpitas CA, US
Benjamin Spink - San Carlos CA, US
International Classification:
A61K 38/48
A61P 7/04
C12N 9/96
US Classification:
424 943, 435188
Abstract:
The present invention relates to compositions comprising factor VII coagulation factors linked to extended recombinant polypeptide (XTEN), isolated nucleic acids encoding the compositions and vectors and host cells containing the same, and methods of making and using such compositions in treatment of coagulation factor-related diseases, disorders, and conditions.

Factor Viii Compositions And Methods Of Making And Using Same

View page
US Patent:
20130017997, Jan 17, 2013
Filed:
Feb 2, 2012
Appl. No.:
13/365166
Inventors:
Volker Schellenberger - Palo Alto CA, US
Pei-Yun Chang - Menlo Park CA, US
Fatbardha Varfaj - Mountain View CA, US
John Kulman - Belmont MA, US
Tongyao Liu - Lexington MA, US
Garabet G. Toby - North Reading MA, US
Haiyan Jiang - Belmont MA, US
Robert Peters - Needham MA, US
Deping Wang - Sharon MA, US
Baisong Mei - Waban MA, US
Joshua Silverman - Sunnyvale CA, US
Chia-Wei Wang - Milpitas CA, US
Benjamin Spink - San Carlos CA, US
Nathan Geething - San Juan PR, US
Assignee:
Amunix Operating Inc. - Mountain View CA
International Classification:
C07K 19/00
A61P 7/04
A61K 38/37
US Classification:
514 141, 530383
Abstract:
The present invention relates to compositions comprising factor VIII coagulation factors linked to extended recombinant polypeptide (XTEN), isolated nucleic acids encoding the compositions and vectors and host cells containing the same, and methods of making and using such compositions in treatment of factor VIII-related diseases, disorders, and conditions.

Binding Fusion Proteins, Binding Fusion Protein-Drug Conjugates, Xten-Drug Conjugates And Methods Of Making And Using Same

View page
US Patent:
20130165389, Jun 27, 2013
Filed:
Sep 28, 2012
Appl. No.:
13/631361
Inventors:
Volker Schellenberger - Palo Alto CA, US
Joshua Silverman - Sunnyvale CA, US
Chia-wei Wang - Milpitas CA, US
Benjamin Spink - San Carlos CA, US
Willem P. Stemmer - Los Gatos CA, US
Susan E. Alters - Palo Alto CA, US
Nathan Geething - SanJuan PR, US
Assignee:
Amunix Operating Inc. - Mountain View CA
International Classification:
C07K 16/24
C07K 14/00
C07K 16/18
C07K 16/40
US Classification:
514 193, 530350
Abstract:
The present invention relates to binding fusion protein compositions comprising targeting moieties linked to extended recombinant polypeptide (XTEN), binding fusion protein-drug conjugate compositions, and XTEN-drug conjugate compositions, isolated nucleic acids encoding the compositions and vectors and host cells containing the same, and methods of using such compositions in treatment of diseases, disorders, and conditions.
Control profile
Benjamin John Spink from San Carlos, CA, age ~48 Get Report